Citigroup Inc Magenta Therapeutics, Inc. Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$0.36 - $1.59 $12 - $57	36 Added 5.14%	737 $0
Q3 2022 Nov 10, 2022	SELL	$1.26 - $2.09 $602 - $999	-478 Reduced 40.54%	701 $1,000
Q2 2022 Aug 10, 2022	SELL	$0.97 - $3.08 $1,151 - $3,655	-1,187 Reduced 50.17%	1,179 $1,000
Q1 2022 May 12, 2022	SELL	$2.55 - $5.23 $17,923 - $36,761	-7,029 Reduced 74.82%	2,366 $7,000
Q4 2021 Feb 10, 2022	BUY	$4.43 - $8.33 $13,188 - $24,798	2,977 Added 46.39%	9,395 $42,000
Q3 2021 Nov 10, 2021	BUY	$6.07 - $9.89 $38,957 - $63,474	6,418 New	6,418 $47,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.